New hope for tough blood cancers: first human trial begins

NCT ID NCT06313593

Recruiting now Disease control Sponsor: Incyte Corporation Source: ClinicalTrials.gov ↗

Summary

This is the first study in people to test a new drug called INCB160058 for myeloproliferative neoplasms (MPNs), a group of rare blood cancers. The main goal is to find a safe dose and see how the body processes the drug in 186 adults whose current treatments have stopped working. Researchers will also check if the drug helps reduce symptoms like spleen enlargement and fatigue.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aou Policlinico S. Orsola-Malpighi
NOT_YET_RECRUITING

Bologna, 40138, Italy
Azienda Ospedaliero-Universitaria Careggi (Aouc)
NOT_YET_RECRUITING

Florence, 50134, Italy
Cornell Medical Center
RECRUITING

New York, New York, 10021, United States
Dana Farber Cancer Institute
WITHDRAWN

Boston, Massachusetts, 02215, United States
Fondazione Irccs Ca Granda Ospedale Maggiore
NOT_YET_RECRUITING

Milan, 20122, Italy
Genesiscare Oxford
NOT_YET_RECRUITING

Oxford, OX4 6LB, United Kingdom
Guys and St Thomas Nhs Foundation Trust
NOT_YET_RECRUITING

London, SE1 9RT, United Kingdom
Haukeland University Hospital
NOT_YET_RECRUITING

Bergen, N-5021, Norway
Hopital Maisonneuve-Rosemont, Montreal, Qc
NOT_YET_RECRUITING

Montreal, Quebec, H1T 2M4, Canada
Hospital Saint Louis
RECRUITING

Paris, 75010, France
Icahn School of Medicine At Mount Sinai
RECRUITING

New York, New York, 10029, United States
Inselspital - Universitaetsspital Bern
NOT_YET_RECRUITING

Bern, 03010, Switzerland
Institut Gustave Roussy
NOT_YET_RECRUITING

Villejuif, 94805, France
McGill University Jewish General Hospital
NOT_YET_RECRUITING

Montreal, Quebec, H3T 1E2, Canada
Md Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States
Oregon Health & Science University
RECRUITING

Portland, Oregon, 97239, United States
Oslo University Hospital
NOT_YET_RECRUITING

Oslo, 00372, Norway
Princess Margaret Cancer Center
NOT_YET_RECRUITING

Toronto, Ontario, M5G 2M9, Canada
Sloan Kettering Institute For Cancer Research
RECRUITING

New York, New York, 10065, United States
Stanford University
RECRUITING

Palo Alto, California, 94304, United States
The University of Alabama At Birmingham
RECRUITING

Birmingham, Alabama, 35249, United States
The University of Kansas Cancer Center Kucc University of Kansas Clinical Research Center
RECRUITING

Fairway, Kansas, 66205, United States
Universitatsklinikum Essen
NOT_YET_RECRUITING

Essen, 45147, Germany
Universitatsklinikum Halle (Saale)
NOT_YET_RECRUITING

Halle, 06120, Germany
Universitatsspital Zurich
NOT_YET_RECRUITING

Zurich, 08091, Switzerland
University Medical Center Rwth Aachen
NOT_YET_RECRUITING

Aachen, D-52074, Germany
University of Michigan
NOT_YET_RECRUITING

Ann Arbor, Michigan, 48109-5008, United States
University of Pennsylvania Health System
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Vanderbilt-Ingram Cancer Center
RECRUITING

Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.

MYELOPROLIFERATIVE NEOPLASMS